Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of “Moderate Buy” by Brokerages

Posted by Geri Gentry on Sep 7th, 2026

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $100.00.

A number of analysts recently weighed in on MMSI shares. BTIG Research restated a “buy” rating and issued a $105.00 price target on shares of Merit Medical Systems in a research note on Tuesday, August 11th. Raymond James Financial reissued an “outperform” rating and issued a $100.00 target price on shares of Merit Medical Systems in a report on Friday, July 31st. Barrington Research set a $114.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Bank of America increased their price target on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Finally, Zacks Research upgraded shares of Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 25th.

Get Our Latest Stock Analysis on Merit Medical Systems

Institutional Trading of Merit Medical Systems

Several institutional investors and hedge funds have recently modified their holdings of MMSI. California State Teachers Retirement System boosted its stake in shares of Merit Medical Systems by 6,636.5% during the second quarter. California State Teachers Retirement System now owns 4,682,184 shares of the medical instruments supplier’s stock valued at $324,663,000 after acquiring an additional 4,612,679 shares during the last quarter. State Street Corp increased its position in Merit Medical Systems by 1.5% during the 4th quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock worth $196,645,000 after purchasing an additional 32,459 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in Merit Medical Systems by 3.9% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock valued at $149,407,000 after purchasing an additional 81,030 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Merit Medical Systems by 12.7% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after purchasing an additional 234,682 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in Merit Medical Systems by 7.0% in the 4th quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock valued at $116,963,000 after purchasing an additional 86,504 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

Shares of NASDAQ:MMSI opened at $89.60 on Wednesday. The company has a market capitalization of $5.35 billion, a PE ratio of 37.02, a P/E/G ratio of 2.24 and a beta of 0.49. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. Merit Medical Systems has a twelve month low of $59.74 and a twelve month high of $94.75. The firm has a 50 day simple moving average of $81.85 and a 200-day simple moving average of $73.16.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The firm’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, equities analysts predict that Merit Medical Systems will post 3.84 EPS for the current fiscal year.

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.